Work

A Phase II Study of the Dual mTOR Inhibitor MLN0128 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.e16529

Authors: Dana E. Rathkopf, Susan F. Slovin, Karen A. Autio, Anthony Delacruz, Gregory Shelkey, Katherine Pisano, Melanie Hullings, Mia DeNunzio, Michael J. Morris, Howard I. Scher

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889730271

Cites:

Cited by: 3

Related to: 10